{"id":"pneumococcal-disease-prevention","safety":{"commonSideEffects":["injection site pain","fatigue","headache","muscle pain","fever"],"contraindications":["severe allergic reaction to any vaccine component"]},"_chembl":{"chemblId":"CHEMBL5315095","moleculeType":"Unknown"},"modality":"Biologic","_dailymed":null,"mechanism":{"target":"Streptococcus pneumoniae capsular polysaccharides","explanation":"Pneumococcal vaccines contain purified capsular polysaccharides or polysaccharide-protein conjugates from multiple serotypes of Streptococcus pneumoniae. Upon administration, the vaccine triggers an immune response that generates protective antibodies, providing immunity against pneumococcal infections caused by the included serotypes.","oneSentence":"Stimulates the immune system to produce antibodies against Streptococcus pneumoniae capsular polysaccharides."},"_scrapedAt":"2026-03-28T01:29:20.306Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779122737,"model":"claude-sonnet-4-5-20250929"},"competitors":[{"name":"pneumococcal 13-valent conjugate vaccine","brand":"Prevnar 13","company":"Pfizer","rationale":"Established pneumococcal conjugate vaccine for disease prevention"},{"name":"pneumococcal 20-valent conjugate vaccine","brand":"Prevnar 20","company":"Pfizer","rationale":"Expanded serotype coverage pneumococcal vaccine"},{"name":"pneumococcal 15-valent conjugate vaccine","brand":"Vaxneuvance","company":"Merck","rationale":"Alternative pneumococcal conjugate vaccine option"},{"name":"pneumococcal polysaccharide vaccine","brand":"Pneumovax 23","company":"Merck","rationale":"23-valent polysaccharide vaccine for pneumococcal prevention"}],"description":"A pneumococcal vaccine in Phase 3 development by Beijing Minhai Biotechnology Co., Ltd for the prevention of pneumococcal disease. Pneumococcal vaccines protect against infections caused by Streptococcus pneumoniae bacteria, including pneumonia, meningitis, and bloodstream infections.","indications":{"approved":[{"status":"investigational","condition":"Pneumococcal disease prevention","patientPopulation":"General population"}]},"trialDetails":[{"nctId":"NCT07488520","phase":"PHASE4","title":"Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire","status":"NOT_YET_RECRUITING","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2026-04","conditions":"Sickle Cell Disease (SCD)","enrollment":120},{"nctId":"NCT06647407","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-05","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":750},{"nctId":"NCT02518555","phase":"PHASE2","title":"Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jennifer Woyach","startDate":"2016-01-12","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":42},{"nctId":"NCT05060146","phase":"NA","title":"Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2022-09-19","conditions":"Streptococcus Pneumoniae Infection","enrollment":646},{"nctId":"NCT06608199","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine","status":"RECRUITING","sponsor":"Beijing Minhai Biotechnology Co., Ltd","startDate":"2024-11-01","conditions":"Pneumococcal Vaccines, Pneumococcal Infections","enrollment":500},{"nctId":"NCT04909268","phase":"","title":"Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2020-12-01","conditions":"Pneumonia, Pneumococcal, Hiv","enrollment":94},{"nctId":"NCT04080531","phase":"PHASE4","title":"Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-10-18","conditions":"Plasma Cell Neoplasm","enrollment":165},{"nctId":"NCT04303494","phase":"","title":"Predictive Value of Heart Rate Variability on Cardiorespiratory Events","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-07-01","conditions":"Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)","enrollment":292},{"nctId":"NCT05481801","phase":"","title":"Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)","status":"COMPLETED","sponsor":"Castilla-La Mancha Health Service","startDate":"2022-09-01","conditions":"Type 1 Diabetes","enrollment":300},{"nctId":"NCT00688870","phase":"PHASE3","title":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2008-06-05","conditions":"Vaccines, Pneumococcal Conjugate Vaccine","enrollment":168},{"nctId":"NCT02274415","phase":"PHASE2","title":"Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-09-16","conditions":"Invasive Pneumococcal Infections, Sickle Cells Disease","enrollment":116},{"nctId":"NCT03619252","phase":"PHASE4","title":"Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents","status":"COMPLETED","sponsor":"Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology","startDate":"2018-07-01","conditions":"Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia","enrollment":36},{"nctId":"NCT03449459","phase":"EARLY_PHASE1","title":"Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2018-12-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":144},{"nctId":"NCT00427895","phase":"PHASE3","title":"Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-02-27","conditions":"Pneumococcal Infections","enrollment":2141},{"nctId":"NCT00000947","phase":"NA","title":"A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":850},{"nctId":"NCT00000933","phase":"","title":"Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections, Pneumococcal Infections","enrollment":326},{"nctId":"NCT03478254","phase":"","title":"Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1).","status":"COMPLETED","sponsor":"Jesús Moreno Fernández","startDate":"2017-12-01","conditions":"Type 1 Diabetes Mellitus","enrollment":300},{"nctId":"NCT03502291","phase":"PHASE4","title":"The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study","status":"COMPLETED","sponsor":"Liverpool University Hospitals NHS Foundation Trust","startDate":"2015-08","conditions":"Pneumonia, Influenza, Human","enrollment":324},{"nctId":"NCT00657709","phase":"PHASE3","title":"Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2008-03","conditions":"Serogroup B Meningococcal Meningitis","enrollment":3630},{"nctId":"NCT00327665","phase":"PHASE1","title":"Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05-01","conditions":"Infections, Streptococcal","enrollment":335},{"nctId":"NCT02034877","phase":"PHASE4","title":"13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India","status":"COMPLETED","sponsor":"Pfizer","startDate":"2014-08","conditions":"Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC","enrollment":1200},{"nctId":"NCT00381615","phase":"PHASE2","title":"Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2006-09","conditions":"Healthy","enrollment":147},{"nctId":"NCT00721396","phase":"PHASE2","title":"Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2008-08","conditions":"Meningococcal Infections","enrollment":1885},{"nctId":"NCT00744263","phase":"PHASE4","title":"Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Pneumonia, Pneumococcal, Pneumococcal Infections, 13-valent Pneumococcal Vaccine","enrollment":84496},{"nctId":"NCT00488683","phase":"PHASE2","title":"B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2007-07","conditions":"Meningococcal Disease","enrollment":216},{"nctId":"NCT00307008","phase":"PHASE2","title":"Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-10","conditions":"Streptococcus Pneumoniae Vaccines","enrollment":1198},{"nctId":"NCT01432262","phase":"PHASE3","title":"13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-07","conditions":"Pneumococcal Infections","enrollment":324},{"nctId":"NCT00227188","phase":"","title":"Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-05","conditions":"Invasive Pneumococcal Disease","enrollment":408},{"nctId":"NCT00873431","phase":"PHASE1","title":"Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47","status":"COMPLETED","sponsor":"Valneva Austria GmbH","startDate":"2009-03","conditions":"Pneumococcal Infections","enrollment":32},{"nctId":"NCT01403805","phase":"NA","title":"Effects of the Oral Care With Vaccines for Pneumonia in Elderly; Going Home Together Both Physician and Dentist","status":"COMPLETED","sponsor":"Yubari Kibounomori","startDate":"2009-11","conditions":"Pneumonia","enrollment":199},{"nctId":"NCT00689351","phase":"PHASE2","title":"Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2008-06","conditions":"Pneumococcal Vaccine","enrollment":180},{"nctId":"NCT00488800","phase":"","title":"Safety and Local Tolerability of Prevenar in Indian Children","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-07","conditions":"Pneumococcal Infections","enrollment":1000},{"nctId":"NCT00378417","phase":"PHASE3","title":"Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"1995-03","conditions":"Otitis Media, Pneumococcal Infections","enrollment":3075}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":36,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"pneumococcal disease prevention","genericName":"pneumococcal disease prevention","companyName":"Beijing Minhai Biotechnology Co., Ltd","companyId":"beijing-minhai-biotechnology-co-ltd","firstApprovalDate":"","aiSummary":"Pneumococcal disease can be prevented through vaccination, as indicated by ClinicalTrials.gov, which has studied the effects of pneumococcal vaccination in preventing conditions such as pneumonia and pneumococcal infections. According to ChEMBL, pneumococcal vaccination works by inducing an immune response, a biological mechanism that is consistent with the use of vaccines as a preventive measure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}